MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
KANT
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Kineta (KANT) Ownership - Who owns Kineta?

Kineta Inc is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.37M
P/E Ratio
N/A
Total Cash
900K
Projected Growth
N/A
Total Debt
710K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.07
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

KANT
Capitalization
3.37M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
900K
Total Cash/Share
0.07
Total Debt
710K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
-8.14M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
0.14
Current Revenue Per Employee
430083.34
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
2.78K
Shares Outstanding - Current
12.3M
Total Liabilities
9.38M
Total Volume MTD
N/A
Value
1
Gain YTD
-21.462
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details